awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38406512-C089E8D1-C0B2-4C13-BEE7-B4C3D73C57BF
Q38406512-C089E8D1-C0B2-4C13-BEE7-B4C3D73C57BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38406512-C089E8D1-C0B2-4C13-BEE7-B4C3D73C57BF
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients.
P2860
Q38406512-C089E8D1-C0B2-4C13-BEE7-B4C3D73C57BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38406512-C089E8D1-C0B2-4C13-BEE7-B4C3D73C57BF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c14fb2d5e681c3b8ae28e5cbef84be98cbf4e5a7
P2860
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).